| Execution period | By December 31, 2026 |
|---|
NSE filing, NSE: PARAS. Summary written from the filing by ALFA Finder's alert engine.
Paras Defence and Space Technologies Ltd: key numbers
- Share price
- ₹1,278.50
- Market cap
- ₹10,303 Cr
- Revenue (annual)
- ₹476.6 Cr
- Net profit (annual)
- ₹88.10 Cr
- P/E (TTM)
- 99.0×Sector 52.6×
- Promoter holding
- 53.20%+0.00% QoQ
- FII holding
- 7.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Paras Defence and Space Technologies Ltd
All →Paras Defence and Space Technologies Annual General Meeting
Paras Defence seeks postal ballot approval for related party transactions with subsidiary Paras Anti-Drone, capped at Rs 150 Crore. E-voting runs until 4 December 2026.
Paras Defence and Space Technologies Q2 FY27 Results: Net Profit ₹30.6 Cr, Up 56.9% YoY
Paras Defence and Space Technologies Ltd reported revenue from operations of ₹151.1 Cr (+43.0% YoY) and net profit of ₹30.6 Cr (+56.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹30.6 Cr · +56.9% YoY
Paras Defence and Space Technologies Board Meeting Date
Paras Defence and Space Technologies will hold a board meeting on October 29, 2026 to consider unaudited quarter results. Results will include standalone and consolidated figures.
Paras Defence and Space Technologies Other Announcement
Paras Defence filed the Regulation 74(5) certificate from its registrar for the quarter ended September 30, 2026, confirming no dematerialization requests.
Paras Defence and Space Technologies Credit Rating
Paras Defence and Space Technologies Limited announced that ICRA Limited upgraded its long-term and short-term credit facilities to [ICRA]A from [ICRA]A-, with a stable outlook.
Paras Defence and Space Technologies Bags ₹26.59 Cr Order from Defence Research and Development Organisation, Ministry of Defence
Paras Defence and Space Technologies Ltd secured a Rs. 26.59 Crore order from DRDO. The project involving a Space-Borne System is scheduled for completion by September 2027.
- Value
- ₹26.59 Cr
- From
- Defence Research and Development Organisation (DRDO), Ministry of Defence
- Execution
- On or before 27 September 2027
Other merger & restructuring announcements
All →Fermenta Biotech Merger & Restructuring
Fermenta Biotech Limited's board has approved the closure of its inactive wholly-owned subsidiary, Fermenta Biotech (UK) Limited. The move aims to reorganize corporate structure and reduce compliance costs following the UK's exit from the EU.
Thomas Cook (India) Merger & Restructuring
Thomas Cook (India) Ltd announced that the NCLT Mumbai Bench has issued directions regarding its composite scheme of arrangement. The scheme involves demergers and amalgamations with Sterling Holiday Resorts and other group entities.
Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days